Abfero Pharmaceuticals, Inc clinical trials
Acquired by Pharmacosmos A/S, 2021 · source ↗
The registry lists 1 studies whose lead sponsor is Abfero Pharmaceuticals, Inc. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 5, 2020.
Before and after it joined Pharmacosmos A/S
- First submitted before Abfero Pharmaceuticals, Inc became part of Pharmacosmos A/S
- 1
- First submitted after Abfero Pharmaceuticals, Inc became part of Pharmacosmos A/S
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Abfero Pharmaceuticals, Inc1 study
Something wrong with this grouping? Tell us on the Pharmacosmos A/S page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Pharmacosmos A/S studies →
- SP-420 in Subjects With Transfusion-dependent Beta-Thalassemia or Other Rare AnemiasWithdrawnNCT03801889Phase 2
Sponsor listed in the registry: Abfero Pharmaceuticals, Inc · First submitted before Abfero Pharmaceuticals, Inc became part of Pharmacosmos A/S